Delivery Order SPE2DB24D1021-SPE2DB25FFBDX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Vaxneuvance 0.5 mL syringes valued at $20,502.36. This firm fixed-price delivery order, which is set to conclude on September 11, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,370.39 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation. The award represents a single delivery transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes valued at $1,370.34 on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price contract represents a non-competitive set-aside and will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,740.70 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on August 19, 2025, with an ultimate completion date of August 20, 2025. This contract utilized firm fixed price pricing and was competitively awarded without any set-aside designation. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of VAXNEUVANCE 0.5 ML syringes valued at $20,438.65 with a firm fixed price contract type. This order is expected to be completed by July 21, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made through a competitive process with no set-aside designation, reflecting AmerisourceBergen's proven capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Vaxneuvance 0.5 ML syringes, valued at $8,058.78. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 20, 2025, with performance to take place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Vaxneuvance is a pneumococcal vaccine indicated for immunization against...
- The Defense Logistics Agency awarded a delivery order valued at $13,360.62 to AmerisourceBergen Drug Corp for Vaxneuvance 0.5 mL syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under the company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $1,791.63 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Vaxneuvance 0.5 mL syringes. This firm fixed-price contract, which is not set-aside, is scheduled for completion by September 19, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single delivery transaction under AmerisourceBergen's existing pharmaceutical supply framework...
- The Defense Logistics Agency awarded a $6,121.40 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vaxneuvance 0.5 ML syringes. This competitive, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- The Defense Logistics Agency awarded a $17,804.46 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Vaxneuvance 0.5 mL syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 22, 2025, and will be performed in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFBDXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Vaxneuvance 0.5 ML syringes with a ceiling value of $6,715.65. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 26, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a critical pharmaceutical supplier to the Department of Defense medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As the prime contractor under this comprehensive IDC, AmerisourceBergen supplies a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices. The current delivery order for Vaxneuvance vaccine demonstrates the company's continued capacity to fulfill critical medical procurement requirements for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 9/25/25 |